CAMBRIDGE, Mass., Feb. 3, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that management will host a conference call on Wednesday, February 10, 2010 at 4:30 p.m. EST. In the conference call, management will review recent research and development and business highlights and Infinity’s full year and fourth quarter 2009 financial results.
To participate in the conference call, please dial 1-800-324-5531 (domestic) and 1-719-325-2359 (international) five minutes prior to start time. A live webcast of the conference call can be accessed in the Investors/Media section of Infinity’s website at www.infi.com. An archived version of the webcast will be available on Infinity’s website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway and fatty acid amide hydrolase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at http://www.infi.com.